- Why Research
- Our Impact
- Get Involved
- About BCRF
- Contact Us
- Cancer Divides. We Unite.
You are here
BCRF investigators report that women at a healthy weight but with high levels of body fat may have an increased risk of breast cancer after menopause.
A study led by BCRF investigator Fergus Couch has shown that 54 BRCA2 variants of uncertain clinical significance are likely to be associated with an increased risk of breast or ovarian cancer.
In Part Three of our series, we explain how to adopt a balanced lifestyle to achieve your wellness goals.
BCRF researchers have uncovered new information about inherited risk of breast cancer for women of Ashkenazi (European) Jewish ancestry. The report was recently published in JAMA Oncology.
FDA approves the first PARP inhibitor for the treatment of HER2-negative metastatic breast cancer in patients with BRCA mutations.
Blood Test Provides Important Prognostic Information for Metastatic Triple Negative Breast Cancer Patients
Research by BCRF investigators shows that tumor DNA collected by liquid biopsy can identify patients at risk of poor outcome.
Researchers shared encouraging results in clinical trials focused on advanced breast cancer
Researchers shared new findings on both treatment and prevention of breast cancer
BCRF shares updates from the largest scientific meeting on breast cancer research.
BCRF reports from the largest international conference on breast cancer research